18th world pharma congress · 2018. 8. 13. · 18th world pharma congress october 18-20, 2018...
TRANSCRIPT
18th World Pharma CongressOctober 18-20, 2018
Warsaw, Poland
S C I E N T I F I C P R O G R A M
conferenceseries.com
SCIENTIFIC PROGRAM
Thursday, 18th October DAY 1Thursday, 18th November
08:30-09:00 Registrations
09:00-09:30 Introduction
09:30-09:50 COFFEE BREAK
09:50-11:50 Meeting Hall 01
KEYNOTE LECTURES
MEETING HALL 01 MEETING HALL 02
11:50-13:10 Talks On: Pharmacological Sciences
Talks On: Pharmacognosy and Phytochemistry
Neuropharmacology Drugs from natural sources
Cardiovascular pharmacology Computational chemistry
Pharmacoepidemiology Telemedicine
Toxicology Proteomics in food & nutrition
13:10-13:15 GROUP PHOTO
13:15-14:00 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
14:00-16:00 Talks On: Pharmaceutical Chemistry Talks On: Drug Targeting and Design
Drug discovery Factors influencing drug targeting
Protein structure prediction and molecular simulation Advances in drug targeting components
Biochemistry Rational drug design
Phytotherapy & complementary medicine Computer aided drug design
Protein structure prediction and molecular simulation Drug design theory
Mass spectrometry techniques Protein Interaction
16:00-16:20 COFFEE BREAK
MEETING HALL 01 (16:20-17:00) MEETING HALL 01 (17:00-18:00)
Young Researchers in Pharmaceutical Sciences
Workshop
Visit: https://world.pharmaceuticalconferences.com/
SCIENTIFIC PROGRAM
Friday, 19th October DAY 2Friday, 19th October
09:00-10:30 Meeting Hall 01
KEYNOTE LECTURES
10:30-10:50 COFFEE BREAK
MEETING HALL 01 MEETING HALL 02
10:50-12:50 Talks On: Pharmaceutical Formulation & Pharmaceutical Manufacturing
Talks On: Pharmaceutical Nanotechnology & Nanomedi-cine and Biomedical Applications
Formulation and pre-formulation development Nanobiomaterials
Formulation types Nano-drugs
Typical formulations Nanomedicines
Powder blending Bionanotechnology and BioMEMS
Milling Nanomedicine for different diseases
Granulation & Hot melt extrusion Best Practices in Personalized and translational medicine
12:50-13:35 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
13:35-15:55 Talks On: Bio-Pharmaceutics and Novel Drug Delivery Systems
Talks On: Pharmaceutical Analysis and Pharmaceutical Process Validation
Biopharmaceutics and drug disposition Pharmaceutical Process Validation
Pharmaceutical technology Chromatography and techniques
Drug discovery and design Spectroscopic techniques
Micelles, Liposomes, Dendrimers and Nano particles Nuclear magnetic resonanace
Hydrogels and Fast dissolving tablets (FDT) Mass spectroscopy
Iontophoresis and Phonophoresis Process validation and drug quality
Erythrocytes, Microspheres & Magnetic microparticles
Types of process validation, Validation protocol and report
15:55-16:15 COFFEE BREAK
MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)
Poster Presentations Workshop
Visit: https://world.pharmaceuticalconferences.com/
SCIENTIFIC PROGRAM
Saturday, 20th October DAY 3Saturday, 20th October
09:00-10:30 Meeting Hall 01
KEYNOTE LECTURES
10:30-10:50 COFFEE BREAK
MEETING HALL 01 MEETING HALL 02
10:50-12:50 Talks On: Pharmaceutical Microbiology and Pharmaceutical Biotechnology
Talks On: Clinical Trials, Clinical Research and Biologics & Biosimilars
Antimicrobial effectiveness testing Clinical research & clinical trials: academic perspective
Sterility testing Clinical trials on different diseases
Environmental monitoring and Rapid screening methods Clinical supply management
Industrial pharma biotechnology CRO, sponsorship & outsourcing for clinical trials
Biomedical data engineering Future of clinical trials and technology innovations
Bioinformatics engineering & Tissue engineering
Challenges and regulatory approach for biosimilars
12:50-13:35 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
13:35-15:55 Talks On: Pharmaceutical Packaging and
Pharmacovigilance & Drug Safety
Talks On: Pharmacy Education and Practice & Regulatory Affairs and Intellectual Property Rights
Future of packaging materials Clinical practice guidelines
Regulatory considerations-China, US, EU, Pharmacopoeia Patient centered pharmacy practice
Packing technology for drug delivery systems Global technical standards
Serialization implementation challenges for pharma companies Critical view of pharmacy education
Postmarketing drug safety Drug regulations and organizations
Adverse event reporting Global pharma products registration
Intellectual property law for generics and innovator rights
15:55-16:15 COFFEE BREAK
MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)
Young Researchers in Pharmaceutical Sciences
Workshop
Awards & Closing Ceremony
Visit: https://world.pharmaceuticalconferences.com/
18th World Pharma
Congress
October 18-20, 2018 Warsaw, Poland
AGENDA
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Andrea Gelain took a master degree in Pharmacy and a
master degree in Chemistry and Pharmaceutical
Technologies. Worked for three years as a
Pharmaceutical technologies researcher in
Pharmaceutical Technologies department of the Milan
Università degli Studi upon the formulation and
preformulation of new conventional release and
modified release solid dosage forms. Since 2016 works
as Process Development Scientist and in R&D
department in Freund-Vector Corporation
Vishal Mhatre is a Pharmacist with 25 years of
experience in pharma industry. Regulatory Domain
Consultant with substantial expertise in Regulatory
project management, strategy development and
Regulatory Operations related work. He has extensive
knowledge and understanding of applicable
Pharmaceutical, Biological and Biotech regulations
covering different types of submissions during the entire
Product Lifecycle management.
Sohair Aly hassan, Ph.D., is academic scientist with
over 25 years’ experience leading multi-disciplinary
international line and matrix-research teams spanning
target identification to clinical candidate selection.
Sohair also has broad academic experience in
physiology teaching modalities with a record of
successful enterprise leadership and collaborative
working
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Abdelmohsen Soliman has his expertise in evaluation
the effect of new drug delivery systems containing
polymeric nanoparticles in protection and treatment of
some diseases such as Alzheimer and cancer for
improving the health. He worked for more than 20 years
on molecular biology, immunology, parasitology, drug
delivery systems formulations and the biological use of
newly synthesized organic compounds for protection
and treatment of some diseases
Isabell Koinig, PhD, is a Postdoctoral Researcher at the
Department of Media and Communications at the
Alpen-Adria University of Klagenfurt, Austria. She just
finished her dissertation investigating how different
pharmaceutical advertising appeals are received in a
cross-cultural context. Her research interests
predominantly concern the areas of health
communication, intercultural advertising,
organizational developments and communication
practices, CSR reporting as well as media and
convergence management
Fereidoon Bondarian, Ph.D. candidate of molecular
genetic in Azad University Science and Research
Branch, Tehran, Iran. About 2 years, he is working on
effect of herbal plants extracts and their secondary
metabolites, and effect of their metabolites in
antiprolifrative of cancer like colorectal cancer and
breast cancer.
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Tamara Athamneh completed the master in
pharmaceutical technology at Jordan University
of science and technology. She worked as a
tutor student in pharmaceutical technology
department as well as part time lecturer at
Jordan University of Science and Technology.
She is currently doing her PhD in Pharmacy at
Hamburg University and Hamburg University
of Technology
His research interests comprise synthetic organic;
Asymmetric synthesis: Asymmetric Michael Reaction;
Medicinal Chemistry in the field of alzheimer’ disease,
HIV, cancer, leishmaniasis, and malaria; Pharmaceutical
Chemistry: Biotransformation, QSAR In Organic
Chemistry. He is the author or co-author of over 90
scientific papers. He is responsible for the Master
degree in Pharmaceutical sciences
Dinah Weissmann is Alcediag’s Executive VP R&D
and CSO, a biotech company dedicated to the
development of innovative diagnostics based on
epigenetic biomarkers mainly RNA editing. Dinah is
also co-Director of a public-private laboratory,
Sys2Diag, that was created in 2015 and dedicated to the
understanding the molecular basis of complex diseases.
Her research background includes 15 years as Director
of Research at the CNRS (French academic research
institute) and various leader positions in pharma
company and biotech
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Dr. Kimberly Stieglitz is a professor of biotechnology
and chemistry at Roxbury Community College and,
since 2005, an adjunct professor of chemistry at Bunker
Hill Community College. She received her Ph.D. from
Boston University Medical School in biophysics and
was a visiting professor at University of Massachusetts
Boston (UMB) for two years, teaching biochemistry
lecture and laboratory sections in biochemistry and
organic chemistry courses. Dr. Stieglitz has published
over 23 articles in peer reviewed journals as well as two
laboratory manuals for general chemistry.
Dr. Kontoyianni holds a PhD in computational
chemistry from the University of North Carolina,
Chapel Hill, and is an Associate Professor of
Pharmaceutical Sciences at Southern Illinois
University Edwarsdville. Before joining the SIUE
School of Pharmacy, she worked in Research &
Development of Fortune 500 companies such as
Johnson & Johnson and Procter & Gamble. Dr.
Kontoyianni’s interests involve the development of
computational methodologies to understand ligand
recognition, and implementation of processes to
accelerate drug discovery. She sits on the editorial
board of several journals, holds seven patents, is a
clinical advisors consultant, and a panelist for the
European Union large scale grant application
proposals, NIH and SBIR.
Mariel PIETRI is currently a PhD student at the
Université Nice Sophia-Antipolis, under the guidance of
the Drs Catherine HEURTEAUX and Marc
BORSOTTO. Her work mainly focuses is the
development of new treatment for stroke and depression,
targeting the TREK-1 channel. Mariel works on the
development of Spadin and its analogs as a new medicine
and her thesis project focuses more specifically on the
protection against stroke.
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Serge Bottari, obtained his M.D. and Ph.D. degrees at
the Free University Brussels, Belgium. He specialized in
OB/GYN and Biochemistry and was a Post-Doctoral
Fellow and Research Associate at UC San Francisco.
After having been a project leader at Sandoz and CIBA-
Geigy, he became Professor of Cell Biology at the
Medical School in Grenoble and Head of Endocrine
Biology in 1993. He published over 65 articles in
premium journals and is member of several editorial
boards.
Prof. A M Lone completed his Ph.D in Medicinal
Chemistry from Indian Institute of Integrative Medicine
(IIIM) Jammu and is currently working as Assistant
Professor in the Department of Chemistry Govt Degree
College for Women Baramulla. He has expertise in the
total synthesis of bioactive molecules, development of
novel strategies and structural modification of natural
molecules for lead optimization.
Dr. Anil S. Solanki is a Principal at APMC College of
Pharmaceutical Education and Research, Himatnagar,
Gujarat. India. He has more than 10 publication and
guided more than 15 students in Masters in Pharmacy.
He has good research hands on controlled and sustained
release novel drug delivery system. He is also doing
research on nano technology which is likely to have
good outcome.
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Highly innovative and result oriented research scientist
with a broad-based research knowledge within
biochemistry and biocatalysts. Strong experience in
protein expression and application in catalysis
chemistry using new technologies. Ability to
successfully meet scientific challenges and execute
multiple tasks both individually and within teams.
Effective in communication of scientific content to a
variety of audiences. Seek to contribute to a dynamic
research team and lead projects with further develop my
research experience, science skills, and project
development.
Ashraf O. Abdellatif is a PhD student at Microbiology
and Immunology Department, Faculty of Pharmacy,
Cairo University and he has published five papers in
reputed journals.
Dr Asit Kumar Chakraborty was performed his PhD at
Indian Institute of Chemical Biology, Kolkata and
awarded PhD degree in 1990 from the Biochemistry
department of Calcutta University. He did postdoctoral
work at University of California at Berkeley and went to
Johns Hopkins University School of Medicine as
visiting faculty. Presently, he is Senior Research Officer
and Associate Professor of Biochemistry at OIST,
Vidyasagar University.
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Buh Amos Wung is currently a research fellow at the
University of Buea, Cameroon. He is a service-oriented
public health practitioner with over six years background
in clinical and teaching environments. Core
competencies include clinical management of patients,
computing, Epi Info, STATA basics and conducting
research as well as excellent communication and time
management skills.
Dr. Dhatrak is working as Assistant Professor at
Department of Chemistry, Savitribai Phule Pune
University, Pune, India. He works in the fields of total
synthesis of natural products and alkaloids. Besides the
total synthesis design and development of novel
instrumentation for chemistry is one of his passions.
Synthesis of naturally occurring pharmacologically
important molecules is an important endeavor for
scientists and the his efforts has led to development of
novel synthetic routes for few pharmacologically
important products.
Dina A. Ghroaba is a Clinician Genetic and Genomic
Physician Scientist and an internationally esteemed
author who has been serving as an editorial board
member of repute journals. She had completed her
M.Sc. in Biochemistry- Molecular Diagnosis of Genetic
Diseases from the Faculty of Science- Ain Shams
University and is currently pursuing Medicine as well as
PhD studies. Her researches aim to serve Diagnostic
Genetics and Gene-Based Therapeutics.
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Väino Sammelselg has completed his PhD in 1989 from
Institute of Physics of Estonian Academy of Sciences
and following years was visiting resercher in several
universities of Finland and Sweden. In 2003 was elected
inorganic chemistry professor in the Institute of
Chemistry of University of Tartu, is serving today also
as head of materials science department in the Institute
of Physics. He has published more than 140 papers
referred in WOS database, and has h-index 32.
Gulay Yelken Demirel has a degree in Department of
Chemistry from University of Gazi (Ankara, Turkey)
followed by a master degree in Medicinal and
Pharmaceutical Chemistry (faculty of pharmacy) from
the same university and studied Executive Master of
Business Administration at Istanbul University.
Currently, She has an ongoing PhD in Medicinal and
Pharmaceutical Chemistry (faculty of pharmacy) at
Yeditepe University. She is also a Turkish Patent
Attorney. She has eleven years’ experience in R&D
department of generic pharmaceutical companies. She
worked as formulation scientist at the Pharmaceutical
Technology Department of Nobel Pharmaceuticals.
Presently, She owns the R&D Project Group
Executive position at Sanovel Pharmaceuticals. She
has several published papers in the academic areas and
over 100 patents & patent applications in the industrial
areas on pharmaceutical dosage forms.
Dr. Howida Kamal Ibrahim, Ph.D is a professor of
Pharmaceutics and Industrial Pharmacy at Faculty of
Pharmacy, Cairo University and at Misr University of
Science and Technology, Egypt. She got her B.Sc.
M.SC and Ph.D. in Pharmaceutical sciences from Cairo
University. She had several publications in different
fields of Pharmaceutical sciences. She is a consultant for
the Central Administration of Pharmaceutical Affairs,
the regulatory body of the Egyptian Drug Authority. She
also works in collaboration with some of the national
Egyptian Drug manufacturers on developing generics
for local registration
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Jun Ou has completed his PhD at the age of 40 years
from Sichuan University. He is employed as full
professor at Guilin University of Technology, Guilin,
contributing to research and education in the field of
nanotechnology, inorganic chemistry, biometal
biomaterials including electrospun collagen fiber about
the cell-materials interaction in vitro and photodynamic
therapy. He has published more than 20 papers in
reputed journals and received the China Natural Science
and Guangxi Natural Science grant.
Mahesh Vasava is pursuing Ph.D. in the field of
synthetic organic chemistry from Department of
Chemistry, Gujarat University, Ahmedabad, India. He
has his expertise in synthesis of novel biological active
scaffolds as well computational chemistry and biology.
His contextual research based on the synthesis of novel
medicinally important moieties creates new pathways
for improving the development of new drug regimens.
He has master degree in Organic Chemistry and
currently he is working on the development of a novel
chemical compounds to fight against mycobacterium
tuberculosis. Moreover, he awarded with the Rajiv
Gandhi National Fellowship for Ph.D.
Pradeep Kumar, Ph.D. Scholar at Amity Institute Of
microbial Technology, Amity University Rajasthan
under the supervision of Prof. (Dr.) G.K. Aseri. I have
12-month Experience of Work on Synthesis of
dendrimer and its utilization in pharmaceutical
application from the national institute of Immunology,
JNU Campus, New Delhi.
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Rikin Patel is pursuing Ph.D. in the field of
Bioinformatics as well as computational chemistry and
Biology from Department of Botany, Bioinformatics
And Climate Change Gujarat University, Ahmedabad,
India. He has his expertise in developing new tools in
bioinformatics as well computational chemistry and
biology which will help in future drug discovery. His
appropriate research based on the computational
chemistry generates new pathways for improving the
development of new drug regimens. He has master
degree in Bioinformatics and currently his working on
the development of a membrane prediction of novel
chemical compounds. Moreover, His awarded with the
Rajiv Gandhi National Fellowship for M.Phil. and
Ph.D.
Rucha Majmundar Mehta has completed her PhD in
Clinical Nutrition from Bombay University and she
has completed GCP & GvP Auditing studies from
BARQA –UK. She is the director of R Q consultants.
She is an Independent GCP – GvP auditor (Free
Lancer) since 10 years. She developed a Clinical
Research Site in a privately owned small sized
hospital and heading the site till date. She is providing
QA consultation and training to various study sites
and QA department of Pharmaceutical Companies.
She conducts GCP Sessions during Investigators
Meetings globally. She has participated in State,
National and International Conferences of Clinical
Research as a faculty. She is conducting GCP
workshops for Clinical Research Professionals for on-
going basis and during conferences. She is active
member of EFGCP –AWP and RQA.
Yuanpeng Janet Huang Rutgers University, USA
Luke Fisher
Collaborative Drug Discovery, USA
Michael Crider
Southern Illinois University Edwardsville, USA
Susan Ciotti
Nan Bio corporation, USA
Elizabeth Kwong
Kwong Eureka Solutions, Canada
Mariana Babayeva
Touro College of Pharmacy, USA
Stuart R Maudsley
Universiteit Antwerpen, Belgium
Ronald A Hill
The University of Louisiana, USA
Lakshmi Prasanna Kolluru
Medefil Inc, USA
Marvin A. Soriano-Ursúa
Instituto Politécnico Nacional, Mexico
Tarek Aboul-Fadl
Assiut University, Egypt
Priyankar Sen
VIT University, India
Shweta Bhagat
National Institute of Pharmaceutical Education and Research, India
Andreas Bernkop-Schnürch
University of Innsbruck, Austria
Osama Ibrahim
Bio Innovation, USA
Volkmar Weissig
Midwestern University College of Pharmacy Glendale, USA
Christine Dufès
University of Strathclyde, UK
Patrizia Chetoni
University of Pisa, Italy
Fiorenza Rancan
Universitätsmedizin Berlin, Germany
PAST AFFILIATESPA
ST A
FFIL
IATE
S
Visit: https://world.pharmaceuticalconferences.com/
Steve Rannard
University of Liverpool, UK
Achim Aigner
Leipzig University, Germany
Hyungil Jung
Yonsei University, South Korea
Anton Aleksashkin
Lomonosov Moscow, State University, Russia
Muhammad Irfan Alam
University of Sunderland, UK
Shrawan Baghel
Waterford Institute of Technology, Ireland
Hinojal Zazo Gamez
Universidad of Salamanca, Spain
Stephen Loughran
Queens University Belfast, Ireland
José Crecente
Campo Center
for Research in Molecular Medicinet
and Chronic Diseases (CIMUS)
Spain
Helen McCarthy
Queen’s University Belfast, Ireland
Abdelazim Zaghloul
Kuwait University, Kuwait
Havazelet Bianco-Peled
Technion–Israel Institute of Technology, Israel
Luisa Fiandra
University of Milan, Italy
Catarina Duarte
IBET, Portugal
Paul Fisher
Inovio Pharmaceuticals Inc, USA
Jesus Izaguirre Carbonell
Tokyo University of Science, Japan
Sahar Awwad
UCL School of Pharmacy, UK
PAST AFFILIATESPA
ST A
FFIL
IATE
S
Visit: https://world.pharmaceuticalconferences.com/
PAST AFFILIATESGillian Hutcheon
Liverpool John Moores University, UK
Drazen Raucher
University of Mississippi Medical
Center, USA
Alessandra Maroni
University of Milan, Italy
Shilpa Raut
Amway, USA
Tatiana Hurtado de
Mendoza Sanford Burnham Prebys
Medical Discovery Institute, USA
Flavia Laffleur
University of Innsbruck, Austria
Marco ContardiItalian
Institute of Technology, Italy
Satyanarayana Somavarapu
UCL School of Pharmacy, UK
Marta Truffi
University of Milano, Italy
Imran Saleem
Liverpool John Moores University, UK
Raid Alany
Kingston University, UK
Dimitrios A. Lamprou
University of Kent, UK
Khuloud Al Jamal
King’s College London, UK
Arwyn T Jones
Cardiff University, UK
Joel Richard
IPSEN, France
Steve Hood
GSK, UKPAST
AFF
ILIA
TES
Visit: https://world.pharmaceuticalconferences.com/
Pharma Congress Glimpses
Warsaw Attractions
Łazien
ki K
róle
wskie
Park
-Pal
ace
Com
plex
Chop
in M
useu
m
Old Town
Palace of
Culture and
Science
Royal Castle
Polin
wilanow-palace
Wars
aw
Ris
ing
Mus
eum
Pow
ązki
Cem
eter
y